Angela Pathmanathan

728 total citations
27 papers, 497 citations indexed

About

Angela Pathmanathan is a scholar working on Pulmonary and Respiratory Medicine, Radiation and Radiology, Nuclear Medicine and Imaging. According to data from OpenAlex, Angela Pathmanathan has authored 27 papers receiving a total of 497 indexed citations (citations by other indexed papers that have themselves been cited), including 22 papers in Pulmonary and Respiratory Medicine, 20 papers in Radiation and 15 papers in Radiology, Nuclear Medicine and Imaging. Recurrent topics in Angela Pathmanathan's work include Advanced Radiotherapy Techniques (20 papers), Prostate Cancer Diagnosis and Treatment (16 papers) and Prostate Cancer Treatment and Research (10 papers). Angela Pathmanathan is often cited by papers focused on Advanced Radiotherapy Techniques (20 papers), Prostate Cancer Diagnosis and Treatment (16 papers) and Prostate Cancer Treatment and Research (10 papers). Angela Pathmanathan collaborates with scholars based in United Kingdom, United States and Netherlands. Angela Pathmanathan's co-authors include Alison Tree, Uwe Oelfke, Nicholas van As, Simeon Nill, Linda G.W. Kerkmeijer, Douglas Brand, Alex Dunlop, Trina Herbert, H. McNair and Maria A. Schmidt and has published in prestigious journals such as International Journal of Radiation Oncology*Biology*Physics, CA A Cancer Journal for Clinicians and Physics in Medicine and Biology.

In The Last Decade

Angela Pathmanathan

27 papers receiving 493 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Angela Pathmanathan United Kingdom 9 392 330 304 66 30 27 497
Monica W.K. Kan Hong Kong 10 439 1.1× 290 0.9× 328 1.1× 120 1.8× 27 0.9× 22 486
Irina Vergalasova United States 11 331 0.8× 233 0.7× 301 1.0× 94 1.4× 24 0.8× 45 461
James Kavanaugh United States 13 351 0.9× 249 0.8× 300 1.0× 75 1.1× 11 0.4× 39 503
S.S. Oei Netherlands 10 467 1.2× 416 1.3× 353 1.2× 58 0.9× 27 0.9× 15 567
Masataka Oita Japan 11 400 1.0× 341 1.0× 273 0.9× 68 1.0× 25 0.8× 50 540
J. Welsh United States 3 348 0.9× 194 0.6× 304 1.0× 126 1.9× 21 0.7× 7 416
Ana Vaniqui Netherlands 10 342 0.9× 230 0.7× 308 1.0× 162 2.5× 16 0.5× 25 466
Jie Shan United States 15 420 1.1× 442 1.3× 178 0.6× 40 0.6× 27 0.9× 19 523
Matthew T. Studenski United States 13 316 0.8× 270 0.8× 230 0.8× 77 1.2× 15 0.5× 56 445
Julia Murray United Kingdom 12 288 0.7× 307 0.9× 194 0.6× 58 0.9× 8 0.3× 39 429

Countries citing papers authored by Angela Pathmanathan

Since Specialization
Citations

This map shows the geographic impact of Angela Pathmanathan's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Angela Pathmanathan with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Angela Pathmanathan more than expected).

Fields of papers citing papers by Angela Pathmanathan

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Angela Pathmanathan. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Angela Pathmanathan. The network helps show where Angela Pathmanathan may publish in the future.

Co-authorship network of co-authors of Angela Pathmanathan

This figure shows the co-authorship network connecting the top 25 collaborators of Angela Pathmanathan. A scholar is included among the top collaborators of Angela Pathmanathan based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Angela Pathmanathan. Angela Pathmanathan is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Albertsen, Peter C., Amar U. Kishan, Angela Pathmanathan, et al.. (2025). The contemporary management of prostate cancer. CA A Cancer Journal for Clinicians. 75(6). 552–586. 2 indexed citations
2.
Nicholson, Steve, Juanita Crook, Nick Watkin, et al.. (2025). Standardization of Radiation Therapy to Inguinal and Pelvic Lymph Nodes in Locally Advanced Cancer of the Penis, as Defined by the International Penile Advanced Cancer Trial (InPACT). International Journal of Radiation Oncology*Biology*Physics. 123(1). 171–182. 1 indexed citations
3.
Patel, Priyanka, Alison Reid, Chris Parker, et al.. (2024). Stereotactic Body Radiotherapy for Oligoprogression in Castration-Resistant Prostate Cancer: Early Toxicity Analysis of the TRAP Trial. Clinical Oncology. 36(9). 585–592. 2 indexed citations
4.
Patel, Priyanka, Gerhardt Attard, Aidan Cole, et al.. (2024). 3381: Primary endpoint analysis of TRAP, first prospective Phase II trial of SBRT to oligoprogressive disease prostate cancer (NCT03644303). Radiotherapy and Oncology. 194. S2643–S2645. 2 indexed citations
5.
Sundahl, Nora, Douglas Brand, Chris Parker, et al.. (2024). Weekly ultra-hypofractionated radiotherapy in localised prostate cancer. Clinical and Translational Radiation Oncology. 47. 100800–100800. 2 indexed citations
6.
7.
Dunlop, Alex, Adam Mitchell, Uwe Oelfke, et al.. (2023). Interim Toxicity Analysis From the Randomized HERMES Trial of 2- and 5-Fraction Magnetic Resonance Imaging–Guided Adaptive Prostate Radiation Therapy. International Journal of Radiation Oncology*Biology*Physics. 118(3). 682–687. 18 indexed citations
8.
Alexander, S., H. McNair, Uwe Oelfke, et al.. (2022). Prostate Volume Changes during Extreme and Moderately Hypofractionated Magnetic Resonance Image-guided Radiotherapy. Clinical Oncology. 34(9). e383–e391. 21 indexed citations
9.
Patel, Priyanka, Nina Tunariu, Daniel S. Levine, et al.. (2022). Oligoprogression in Metastatic, Castrate-Resistant Prostate Cancer—Prevalence and Current Clinical Practice. Frontiers in Oncology. 12. 862995–862995. 5 indexed citations
10.
Barnes, Helen, Trina Herbert, Adam Mitchell, et al.. (2022). MRI-guided adaptive radiotherapy for prostate cancer: When do we need to account for intra-fraction motion?. Clinical and Translational Radiation Oncology. 37. 85–88. 2 indexed citations
11.
Dunlop, Alex, Helen Barnes, Douglas Brand, et al.. (2022). Dosimetric comparison of automatically propagated prostate contours with manually drawn contours in MRI-guided radiotherapy: A step towards a contouring free workflow?. Clinical and Translational Radiation Oncology. 37. 25–32. 5 indexed citations
12.
Dunlop, Alex, Adam Mitchell, Alison Tree, et al.. (2020). Daily adaptive radiotherapy for patients with prostate cancer using a high field MR-linac: Initial clinical experiences and assessment of delivered doses compared to a C-arm linac. Clinical and Translational Radiation Oncology. 23. 35–42. 68 indexed citations
13.
Menten, Martin J., Jenny Bertholet, Alex Dunlop, et al.. (2020). Automatic reconstruction of the delivered dose of the day using MR-linac treatment log files and online MR imaging. Radiotherapy and Oncology. 145. 88–94. 55 indexed citations
14.
Pathmanathan, Angela, Anna Andreychenko, Linda G.W. Kerkmeijer, et al.. (2019). Fiducial marker based intra-fraction motion assessment on cine-MR for MR-linac treatment of prostate cancer. Physics in Medicine and Biology. 64(7). 07NT02–07NT02. 32 indexed citations
15.
Pathmanathan, Angela, L. Bower, Helen Creasey, et al.. (2019). EP-1566 MR-guided online adaptive radiotherapy: First experience in the UK. Radiotherapy and Oncology. 133. S845–S845. 3 indexed citations
16.
Herbert, Trina, Helen Creasey, Alex Dunlop, et al.. (2019). EP-2173 Bladder filling in patients undergoing prostate radiotherapy on the MR-linac. Radiotherapy and Oncology. 133. S1200–S1201. 1 indexed citations
17.
Pathmanathan, Angela, Manuel Schmidt, Douglas Brand, et al.. (2018). EP-1613: Comparison of prostate delineation on multi-modality imaging for MR-guided radiotherapy. Radiotherapy and Oncology. 127. S868–S869. 1 indexed citations
18.
Pathmanathan, Angela, Nicholas van As, Linda G.W. Kerkmeijer, et al.. (2017). Magnetic Resonance Imaging-Guided Adaptive Radiation Therapy: A “Game Changer” for Prostate Treatment?. International Journal of Radiation Oncology*Biology*Physics. 100(2). 361–373. 131 indexed citations
19.
Pathmanathan, Angela, et al.. (2016). The Delineation of Intraprostatic Boost Regions for Radiotherapy Using Multimodality Imaging. Future Oncology. 12(21). 2495–2511. 7 indexed citations
20.
Felice, Francesca De, C. Thomas, Sally F. Barrington, et al.. (2015). Analysis of loco-regional failures in head and neck cancer after radical radiation therapy. Oral Oncology. 51(11). 1051–1055. 42 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Monica W.K. Kan Breakdown of academic impact, for papers by Irina Vergalasova Breakdown of academic impact, for papers by James Kavanaugh Breakdown of academic impact, for papers by S.S. Oei Breakdown of academic impact, for papers by Masataka Oita Breakdown of academic impact, for papers by J. Welsh Breakdown of academic impact, for papers by Ana Vaniqui Breakdown of academic impact, for papers by Jie Shan Breakdown of academic impact, for papers by Matthew T. Studenski Breakdown of academic impact, for papers by Julia Murray
Rankless by CCL
2026